Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/04/1995 | US5430058 Pharmaceutical compositions comprising hydroxamate derivatives for iron removal |
07/04/1995 | US5430057 Parenteral busulfan for treatment of malignant disease |
07/04/1995 | US5430052 Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases |
07/04/1995 | US5430051 Photodynamic diagnosis and therapy of rheumatic diseases |
07/04/1995 | US5430050 Hispidospermidin |
07/04/1995 | US5430049 Treating hyperproliferative disorders |
07/04/1995 | US5430048 Spirocyclic benzopyran imidazolines |
07/04/1995 | US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT |
07/04/1995 | US5430044 Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
07/04/1995 | US5430043 Platelet aggregation inhibitors |
07/04/1995 | US5430042 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
07/04/1995 | US5430041 Amino acid derivatives having antiviral activity |
07/04/1995 | US5430039 Treatment of neurological disorders |
07/04/1995 | US5430037 Oxypurinol alkali and alkalane earth salts in amorphous or crystalline form as agents for treating hyperuricaemia and gout |
07/04/1995 | US5430032 Treating asthma, allergy, inflammation |
07/04/1995 | US5430031 Serotoninergic ergoline derivatives |
07/04/1995 | US5430030 Nerve gas antidote |
07/04/1995 | US5430029 Pharmaceutical compositions active in the therapy of sleep disorders |
07/04/1995 | US5430028 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient |
07/04/1995 | US5430027 2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias |
07/04/1995 | US5430026 2'-deoxy-2',2'-difluoro (4-substituted pyrimidine) nucleosides, bicyclic derivatives,pharmaceutical compositions, and synthetic precursors |
07/04/1995 | US5430025 Elastase-inhibiting peptides bearing a C-terminal trifluoromethylketone moiety |
07/04/1995 | US5429938 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
07/04/1995 | US5429510 High-density interconnect technique |
07/04/1995 | CA2138000A1 Retinoid-like compounds |
07/04/1995 | CA2137997A1 Retinoid-like compounds |
07/04/1995 | CA1336195C Aryloxyphenylpropylamines and their preparation and use |
07/04/1995 | CA1336192C Pharmaceutical benzoheterocyclylcarboxamide derivatives |
07/04/1995 | CA1336191C Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
07/04/1995 | CA1336177C Method of producing high molecular weight sodium hyaluronate by fermentation of streptococcus |
07/04/1995 | CA1336169C Agent for treatment of parkinson's disease |
07/04/1995 | CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist |
07/01/1995 | CA2138929A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
07/01/1995 | CA2138877A1 Using a spin acceptor in a cosmetic or dermatological composition |
07/01/1995 | CA2138876A1 Composition against aging by acting simultaneously on the superficial and deep layers of the skin, and its use |
07/01/1995 | CA2138112A1 Water-in-oil emulsion containing retinol, its use and its conditioning |
06/30/1995 | CA2139209A1 Therapeutic agent for hemorrhoidal diseases |
06/30/1995 | CA2112539A1 Medicated herbal lotion |
06/29/1995 | WO1995017507A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE |
06/29/1995 | WO1995017506A1 Mediators of chronic allograft rejection |
06/29/1995 | WO1995017414A1 Anti-hepatitis b viral oligonucleotides |
06/29/1995 | WO1995017411A1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome |
06/29/1995 | WO1995017410A1 Heterocyclic compounds |
06/29/1995 | WO1995017407A1 Tetrahydrofuran antifungals |
06/29/1995 | WO1995017406A1 Anticonvulsant pseudofructopyranose sulfamates |
06/29/1995 | WO1995017405A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
06/29/1995 | WO1995017402A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions |
06/29/1995 | WO1995017401A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
06/29/1995 | WO1995017400A1 N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands |
06/29/1995 | WO1995017399A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
06/29/1995 | WO1995017398A1 Indole, indoline and quinoline derivatives with 5ht1d (anti-depressive) activity |
06/29/1995 | WO1995017397A1 Fibrinogen receptor antagonists |
06/29/1995 | WO1995017396A1 Polymorphs of losartan and the process for the preparation of form ii of losartan |
06/29/1995 | WO1995017393A1 4,5-diaryloxazole derivatives |
06/29/1995 | WO1995017392A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor |
06/29/1995 | WO1995017390A1 N-substituted aryl trifluoromethyl imidazoles |
06/29/1995 | WO1995017389A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
06/29/1995 | WO1995017388A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations |
06/29/1995 | WO1995017385A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs |
06/29/1995 | WO1995017384A1 4-arylisoindole analgesics |
06/29/1995 | WO1995017383A1 Indole derivatives as anti-estrogens |
06/29/1995 | WO1995017382A1 Non-peptide tachykinin receptor antagonists |
06/29/1995 | WO1995017381A1 Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity |
06/29/1995 | WO1995017379A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors |
06/29/1995 | WO1995017214A1 Ethene as a sterilizing agent |
06/29/1995 | WO1995017206A1 Lyophilized stem cell factor formulations |
06/29/1995 | WO1995017201A1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate |
06/29/1995 | WO1995017199A1 Novel therapeutic carbohydrate blends useful for aiding sleep disorders |
06/29/1995 | WO1995017198A1 A novel tumor suppressor gene |
06/29/1995 | WO1995017197A1 Vitamin d3 analogues and pathway to mediate disorders |
06/29/1995 | WO1995017196A1 Psoriasis treatment |
06/29/1995 | WO1995017195A1 Flunisolide aerosol formulations |
06/29/1995 | WO1995017194A1 Composition for a contraceptive comprising an estrogen and a gestagen |
06/29/1995 | WO1995017193A1 Combination contraceptive containing progesterone antagonists and a progestogen |
06/29/1995 | WO1995017192A1 Methods for reducing multidrug resistance |
06/29/1995 | WO1995017191A1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent. |
06/29/1995 | WO1995017190A1 Pharmaceuticals |
06/29/1995 | WO1995017189A1 NEW USE OF δ-OPIOID RECEPTOR ANTAGONISTS |
06/29/1995 | WO1995017188A1 Deuterised active agents in transdermal application |
06/29/1995 | WO1995017187A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin |
06/29/1995 | WO1995017186A1 Use of thalidomide for the treatment of non-insulin dependent diabetes mellitus |
06/29/1995 | WO1995017185A1 A method of treating gastrointestinal motility disorders |
06/29/1995 | WO1995017184A1 Pharmaceutical compositions containing ceftriaxone and penems |
06/29/1995 | WO1995017183A1 Use of pla2 inhibitors as treatment for alzheimer's disease |
06/29/1995 | WO1995017182A1 Protein kinase c inhibitors |
06/29/1995 | WO1995017181A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
06/29/1995 | WO1995017180A1 A method of treating gastrointestinal motility disorders |
06/29/1995 | WO1995017179A1 Stable dermatologic preparation containing mycophenolic acid |
06/29/1995 | WO1995017178A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure |
06/29/1995 | WO1995017177A1 Liquid pharmaceutical compositions based on ibuprofen |
06/29/1995 | WO1995017176A1 Methods for sedating and anaesthetising aquatic organisms |
06/29/1995 | WO1995017174A1 Process for making laxatives containing dioctyl sulfosuccinate |
06/29/1995 | WO1995017170A1 Accelerated release composition containing bromocriptine |
06/29/1995 | WO1995017169A1 Method for dry blend compression of medicaments |
06/29/1995 | WO1995017168A1 Method for preparing low dose pharmaceutical products |
06/29/1995 | WO1995017165A2 Tissue moisturizing and antimicrobial compositions |
06/29/1995 | WO1995017164A1 A pharmaceutical composition for the intranasal administration of hydroxocobalamin |
06/29/1995 | WO1995017154A2 Use of thalidomide for treating neurocognitive disorders |
06/29/1995 | WO1995017103A1 The use of mannan-rich materials in feedstuffs |
06/29/1995 | WO1995017095A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |